Literature DB >> 9891987

Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-kappaB-dependent transcription.

T G Hofmann1, S P Hehner, S Bacher, W Dröge, M L Schmitz.   

Abstract

Glucocorticoids (GCs) influence a great variety of cellular functions by at least three important modes of action: the activation (or repression) of genes controlled by binding sites for the glucocorticoid receptor (GR), the induction of apoptosis in lymphocytes and the recently discovered cross-talk to other transcription factors such as NF-kappaB. In this study we systematically compared various natural and synthetic steroid hormones frequently used as therapeutic agents on their ability to mediate these three modes of action. Betamethasone, triamcinolone, dexamethasone and clobetasol turned out to be the best inducers of gene expression and apoptosis. All GCs including the antagonistic compound RU486 efficiently reduced NF-kappaB-mediated transactivation to comparable extents, suggesting that ligand-induced nuclear localization of the GR is sufficient for transrepression. Glucocorticoid treatment of cells did not result in elevated IkappaB-alpha expression, but impaired the tumor necrosis factor (TNF)-alpha-induced degradation of IkappaB-alpha without affecting DNA binding of NF-kappaB. The structural requirements for the various functions of glucocorticoids are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9891987     DOI: 10.1016/s0014-5793(98)01609-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Anti-inflammatory glucocorticoid drugs: reflections after 60 years.

Authors:  Michael W Whitehouse
Journal:  Inflammopharmacology       Date:  2010-10-31       Impact factor: 4.473

2.  Glucocorticoids potently block tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptotic cell death in bovine glomerular endothelial cells upstream of caspase 3 activation.

Authors:  U K Messmer; G Winkel; V A Briner; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  Glucocorticoids inhibit lipopolysaccharide-induced up-regulation of arginase in rat alveolar macrophages.

Authors:  S Klasen; R Hammermann; M Fuhrmann; D Lindemann; K F Beck; J Pfeilschifter; K Racké
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

4.  Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.

Authors:  Jamie D Croxtall; Peter Th W van Hal; Qam Choudhury; Derek W Gilroy; Rod J Flower
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Role of caspases in dexamethasone-induced apoptosis and activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in human eosinophils.

Authors:  J P Zhang; C K Wong; C W Lam
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

6.  Inhibition by glucocorticoids of the interleukin-1beta-enhanced expression of the mast cell growth factor SCF.

Authors:  Carla Alexandra Da Silva; Olivier Kassel; Eric Mathieu; Gilbert Massard; Bernard Gasser; Nelly Frossard
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

Review 7.  Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.

Authors:  Jonathan P Godbout; Ronald Glaser
Journal:  J Neuroimmune Pharmacol       Date:  2006-08-10       Impact factor: 4.147

8.  Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function.

Authors:  Mark D Trottier; Matthew M Newsted; Louis E King; Pamela J Fraker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

9.  Predicted Biological Activity of Purchasable Chemical Space.

Authors:  John J Irwin; Garrett Gaskins; Teague Sterling; Michael M Mysinger; Michael J Keiser
Journal:  J Chem Inf Model       Date:  2017-12-29       Impact factor: 4.956

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.